Potassium Chloride Injection, Solution, Concentrate
Product Images NDC 0409-6653

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 0409-6653). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Potassium 01)

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Principal Display Panel (5 mL Vial Label)
This is a description of a single-dose injection with 5 mL volume, containing potassium chloride concentrate for intravenous use with the NDC code of 0409-6635-18. It is sterile and nonpyrogenic, with a potential pH adjustment containing no more than 4 mOsmol/mL (calc). It requires dilution before use and must be discarded if any portion remains unused. The dosage instructions are listed on the insert, and the product is distributed by Hospira, Inc. The text also includes the lot number and expiration date but no further details are given.*
FDA Label Image

Principal Display Panel (5 mL Vial Tray)

Principal Display Panel (5 mL Vial Tray)
This is a description of a medication containing potassium chloride. It comes in a concentrate form that must be diluted before use and it is intended for infusion only. The dosage is not specified and users should refer to the insert for dosage information. The medication is non-pyrogenic and sterile with a pH adjusted by hydrochloric acid. Unused portions should be discarded promptly. The medication is distributed by Hospital Loke Forest in the USA and contains 10 mEq/5 mL of potassium chloride in each mL. The code on the package is NDC 0409-6635-01, but the details of another package with code NDC 0409-6635-18 are also included.*
FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
This is a description of a single-dose injection concentrate of Potassium Chloride for intravenous use. Each 10mL contains potassium chloride, 2 mEq (149 mg) which may contain HCl for pH adjustment.It is sterile, nonpyrogenic and contains no more than 100mcg/L of aluminum. It must be diluted before use and the usual dosage instructions can be found in the insert. The product has a LOT number and an expiration date.*
FDA Label Image

Principal Display Panel (10 mL Vial Tray)

Principal Display Panel (10 mL Vial Tray)
This is a potassium chloride concentrate for use in intravenous infusion. It comes in a 20mEq/10mL concentration and each mL contains 2mEq of potassium chloride (149mg). It may contain hydrochloric acid to adjust pH and has a calculated osmolality of 4mosmol/mL. It is sterile and non-pyrogenic, but contains no bacteriostat. It should be used promptly and any unused portion should be discarded. Further dosage details can be found in the insert. It is distributed by Hospira Inc. and has a seal to ensure the product is clear before use.*
FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
This is a description of a single-dose injection of Potassium Chloride, which is used intravenously. The concentrate contains 40mEq/20mL (2mEg/mL) of Potassium Chloride and must be diluted before use. Distributed by Hospira Inc., each mL contains Chloride and 2mEq (149 mg). May contain HCl for pH adjustment, it is sterile and nonpyrogenic. It contains no more than 100 meg/L of aluminum, with a usual dosage specified in the insert. The description provides a lot number, expiration date, and other details.*
FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Principal Display Panel (20 mL Vial Tray)
This appears to be information about a medication containing potassium chloride which is for intravenous infusion only. It contains 2 mEq of potassium chloride per mL. The usual dosage information is provided in the insert. The solution is a bacteriostatic solution that should be used promptly and any remaining unused portions should be discarded. It contains 40 mEq of potassium chloride per 20 mL of concentrate. The concentrate must be diluted before use. The text provides details on the NDC (National Drug Code) and size of the container.*
FDA Label Image

Principal Display Panel (15 mL Vial Label)

Principal Display Panel (15 mL Vial Label)
This is a description of a single-dose injection concentrate containing 2 mEq of potassium chloride per mL, with a concentration of 30 mEq/15 mL. The solution may contain HCl for pH adjustment and is sterile and nonpyrogenic. The usual dosage is found in the insert and any unused portion is to be discarded. The concentrate contains no more than 100 mcg/L of aluminum and must be diluted before use. The manufacturer is Hospira, Inc. located in Lake Forest, IL, USA.*
FDA Label Image

Tray Ndc 0409-6636-01 (Potassium 09)

Tray Ndc 0409-6636-01 (Potassium 09)
Each mL of this solution contains 2 milliequivalents of potassium chloride and is intended for intravenous infusion only. Before administration, it should be diluted and thoroughly mixed, with adjustment of pH if necessary. The solution is sterile, non-pyrogenic and does not contain bacteriostatic agents. The recommended dosage should be followed as per the insert. If unused portions remain, they should be promptly discarded. The also includes some unreadable characters and therefore, the full description may not be available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.